Example: Heart Attack

Search clinical trials for: Hydroxycholecalciferols

Total 174 results

NCT03292744

Unknown status

Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly

Conditions: Frail Elderly Syndrome; Elderly Infection
NCT02895061

Completed

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Conditions: Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
NCT02327091

Completed

The Effect of Alfacalcidol on Muscle Strength in Elderly Indonesian Women : A Randomized Controlled Trial

Conditions: Muscle Weakness
NCT01752244

Unknown status

Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects

Conditions: Obesity
NCT03147677

Completed

Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

Conditions: Type 2 Diabetic Nephropathy
NCT04405960

Completed

Role of Alphacalcidol Supplement to Reduce Pain and COMP in Geriatric Knee Osteoarthritis Patients

Conditions: Osteoarthritis, Knee; Aged
NCT02747381

Completed

The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients

Conditions: Asthma
NCT00828347

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Conditions: Secondary Hyperparathyroidism
NCT03867929

Completed

Serum Levels of 25-Hydroxy Vitamin D in Patients With Moderate and Severe Erectile Dysfunction

Conditions: Erectile Dysfunction
NCT01364688

Unknown status

Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease

Conditions: Vascular Calcification
NCT01115543

Completed

Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

Conditions: Secondary Hyperparathyroidism; End Stage Renal Disease
NCT03576716

Active, not recruiting

Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation

Conditions: Chronic Kidney Disease
NCT02937350

Active, not recruiting

Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease

Conditions: Chronic Kidney Disease
NCT00168909

Completed

Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)

Conditions: Osteoporosis, Postmenopausal; Osteopenia; Falls
NCT04386850

Recruiting

Oral 25-hydroxyvitamin D3 and COVID-19

Conditions: COVID 19
NCT01974167

Unknown status

Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol

Conditions: Osteoporosis
NCT03104855

Completed

Clearance of 25-hydroxyvitamin D in Cystic Fibrosis

Conditions: Cystic Fibrosis
NCT01020253

Unknown status

The Effectiveness of Two Osteoporosis Drugs on Prosthetic Bone Mineral Density (BMD) Loss After Total Hip Arthroplasty(THA)

Conditions: Bone Density; Arthroplasty, Replacement, Hip
NCT04085770

Completed

Short Term Effect of Vitamin D Supplementation on the Clinical Outcomes in Patients Undergoing Valve Replacement Surgery

Conditions: Cardiac Valve Replacement Complication
NCT03210688

Recruiting

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

Conditions: Minimal Change Disease; Nephrotic Syndrome
NCT03334136

Completed

The Effect of Vitamin D Supplementation on Psoriasis Severity

Conditions: Psoriasis; Vitamin D Deficiency
NCT00483275

Withdrawn

Fall Prevention by Alfacalcidol and Training

Conditions: Accidental Falls; Chronic Renal Insufficiency; Aged
NCT01398202

Completed

Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults

Conditions: Vitamin D Status as Reflected by Serum 25-hydroxyvitamin D
NCT00138983

Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

Conditions: Rheumatoid Arthritis; Polymyalgia Rheumatica; Giant Cell Arteritis; Polymyositis; Wegener's Granulomatosis
NCT00668330

Completed

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus